PPARs/RXRs in Cardiovascular Physiology and Disease

PPARs/RXRs in Cardiovascular Physiology and Disease

Saved in:

Bibliographic Details
Main Authors:	Brian N. Finck, Giulia Chinetti, Bart Staels
Format:	Article
Language:	English
Published:	Wiley 2008-01-01
Series:	PPAR Research
Online Access:	http://dx.doi.org/10.1155/2008/173780
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Phytochemicals as Modulators of PPARs and RXRs
by: Joshua K. Ko, et al.
Published: (2010-01-01)

PPARs, RXRs, and Stem Cells
by: Jeffrey M. Gimble, et al.
Published: (2007-01-01)

PPARs, RXRs, and Drug-Metabolizing Enzymes
by: James P. Hardwick, et al.
Published: (2009-01-01)

PPAR in Cardiovascular Disorders
by: Alexander N. Orekhov, et al.
Published: (2016-01-01)

PPAR-γ in the Cardiovascular System
by: Sheng Zhong Duan, et al.
Published: (2008-01-01)

PPARδ Activity in Cardiovascular Diseases: A Potential Pharmacological Target
by: Angela Tesse, et al.
Published: (2009-01-01)

Isoflavones and PPAR Signaling: A Critical Target in Cardiovascular, Metastatic, and Metabolic Disease
by: Rakesh P. Patel, et al.
Published: (2010-01-01)

PPARs and Liver Disease
by: Yasuteru Kondo, et al.
Published: (2013-01-01)

PPARs in Viral Disease
by: Jacqueline Capeau, et al.
Published: (2009-01-01)

Should We Use PPAR Agonists to Reduce Cardiovascular Risk?
by: Jennifer G. Robinson
Published: (2008-01-01)

PPARs in Lung Biology and Disease
by: Theodore J. Standiford, et al.
Published: (2007-01-01)

Does Pro12Ala Polymorphism Enhance the Physiological Role of PPARγ2?
by: A. C. Pereira, et al.
Published: (2013-01-01)

Cardiovascular Pharmacology: Contemporary Physiologic and Scientific Approaches to Cardiovascular Disease Prevention and Treatment
by: James B. Young, et al.
Published: (2022-12-01)

Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases
by: Peng Cheng, et al.
Published: (2016-01-01)

An Introduction to Cardiovascular Physiology /
by: Herring, Neil
Published: (2010)

PPAR Medicines and Human Disease: The ABCs of It All
by: Anthony J. Apostoli, et al.
Published: (2012-01-01)

PPARS and Obesity
by: Francine M. Gregoire, et al.
Published: (2007-01-01)

Cycle Sequencing on Large DNA Templates
by: Lluis Fajas, et al.
Published: (1997-12-01)

Ectopic fat depots: physiological role and impact on cardiovascular disease continuum
by: Anna E. Bragina, et al.
Published: (2022-03-01)

Impact of Phytochemicals on PPAR Receptors: Implications for Disease Treatments
by: Ayesheh Enayati, et al.
Published: (2022-01-01)

Genetic Manipulations of PPARs: Effects on Obesity and Metabolic Disease
by: Yaacov Barak, et al.
Published: (2007-01-01)

PPARs in Rhythmic Metabolic Regulation and Implications in Health and Disease
by: Purin Charoensuksai, et al.
Published: (2010-01-01)

Macrophages, PPARs, and Cancer
by: Jo A. Van Ginderachter, et al.
Published: (2008-01-01)

The Role of PPARs in Cancer
by: Keisuke Tachibana, et al.
Published: (2008-01-01)

Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?
by: Roberto Scatena, et al.
Published: (2008-01-01)

Genetic Variation of PPARs
by: Marie-Claude Vohl, et al.
Published: (2009-01-01)

PPARs and Anticancer Therapies
by: Michael E. C. Robbins, et al.
Published: (2010-01-01)

PPARs, Obesity, and Inflammation
by: Sander Kersten, et al.
Published: (2007-01-01)

PPARs and Bone Metabolism
by: Beata Lecka-Czernik
Published: (2006-01-01)

PPARs and Gastrointestinal Cancer
by: Valerio Pazienza
Published: (2012-01-01)

Metabolomics of the interaction between PPAR‐α and age in the PPAR‐α‐null mouse
by: Helen J Atherton, et al.
Published: (2009-04-01)

Signaling Mechanisms of Selective PPARγ Modulators in Alzheimer’s Disease
by: Manoj Govindarajulu, et al.
Published: (2018-01-01)

PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs
by: Marion Peyrou, et al.
Published: (2012-01-01)

MicroRNAs-Dependent Regulation of PPARs in Metabolic Diseases and Cancers
by: Dorothea Portius, et al.
Published: (2017-01-01)

NO-Donating NSAIDs, PPARδ, and Cancer: Does PPARδ Contribute to Colon Carcinogenesis?
by: Gerardo G. Mackenzie, et al.
Published: (2008-01-01)

Exploring PPAR Gamma and PPAR Alpha’s Regulation Role in Metabolism via Epigenetics Mechanism
by: Małgorzata Małodobra-Mazur, et al.
Published: (2024-11-01)

Conditional Expression of Human PPARδ and a Dominant Negative Variant of hPPARδ In Vivo
by: Larry G. Higgins, et al.
Published: (2012-01-01)

Coordinated Regulation of PPAR𝛾 Expression and Activity through Control of Chromatin Structure in Adipogenesis and Obesity
by: Jérôme Eeckhoute, et al.
Published: (2012-01-01)

Skin-targeted inhibition of PPAR β/δ by selective antagonists to treat PPAR β/δ-mediated psoriasis-like skin disease in vivo.
by: Katrin Hack, et al.
Published: (2012-01-01)

LDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver disease.
by: Veerle Bieghs, et al.
Published: (2012-01-01)